-
Lung Cancer: Targets and Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Lung Cancer: Targets and Therapy
(5,366) Views
Editor in Chief Dr Rajagopal Ramesh
1179-2728
An international, peer-reviewed, open access journal focusing on lung cancer research, identification of therapeutic targets and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.
Founding Author Offer
All authors can now submit their original research papers to Lung Cancer: Targets and Therapy and the publication processing fee will be waived, until further notice. Click here to start the process of submitting your original research paper at no cost.
Indexed online:
- OAIster - The Open Access Initiative
- ResearchGATE scientific network
Article Processing Statistics:
14 From submission of manuscript to first editorial decision (including peer-review)
- Founding Author Offer
Submit your paper to one of these journals and the fee will be waived, until further notice.
